Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 152 of 1,261
  1. US 11839599

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  2. US 11840686

    Modulation of prekallikrein (PKK) expression

    Ionis Pharmaceuticals, Inc. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  3. US 11839594

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    TONIX PHARMA LIMITED Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  4. US 11840497

    4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

    PTC THERAPEUTICS, INC. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  5. US 11839631

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  6. US 11839676

    System, method, and kit for selecting and preparing customized cosmetics

    MEDISCA PHARMACEUTIQUE INC. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  7. US 11839649

    Compositions comprising recombinant probiotic bacteria and methods of use thereof

    United States Government as represented by the Department of Veterans Affairs Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  8. US 11840575

    Engineered immune cells targeting BCMA and their uses thereof

    GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  9. US 11840532

    Modulators of THR-Ξ² and methods of use thereof

    Aligos Therapeutics, Inc. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  10. US 11840581

    Ξ±4Ξ²7 thioether peptide dimer antagonists

    Protagonist Therapeutics, Inc. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  11. US 11840689

    Method of treating fatty liver disease

    Ionis Pharmaceuticals, Inc. Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  12. US 11840690

    Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAs targeting the expanded hexanucleotide repeat

    The Board of Regents of the University of Texas System Β· Granted Dec 12, 2023 Β· Expires Dec 7, 2043

    granted
  13. CN 117186084

    Pranlerivir sulfonate, and pharmaceutical preparation, preparation method and application thereof in treatment of herpes virus

    BAYER HEALTHCARE AG Β· Granted Dec 8, 2023 Β· Expires Dec 3, 2043

    granted
  14. WO 2023232958

    INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE

    ALK ABELLO AS [DK] Β· Granted Dec 7, 2023 Β· Expires Dec 2, 2043

    granted
  15. US 11833157

    Precipitation resistant small molecule drug formulations

    XERIS PHARMACEUTICALS, INC. Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  16. US 11833211

    Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2

    BicycleTx Limited Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  17. US 11834649

    CRISPR/CAS-related methods and compositions for treating herpes simplex virus

    Editas Medicine, Inc. Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  18. US 11833210

    ASH1L inhibitors and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  19. US 11834441

    Substituted tetrahydrofurans as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  20. US 11833217

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  21. US 11833221

    Oligomeric compounds for reducing DMPK expression

    Ionis Pharmaceuticals, Inc. Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  22. US 11834462

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  23. US 11834507

    Anti-MET agonist antibody for use in the treatment of colorectal cancer

    AGOMAB THERAPEUTICS Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted
  24. US 11833199

    Peptide fragments from filoviruses and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Dec 5, 2023 Β· Expires Nov 30, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.